eli lilly news glp-1 Retatrutide, the next generation of drug from Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In Inside the GLP-1 Gold Rush:

Effects of the SGLT2 inhibitor ipragliflozin on food intake, appetite-regulating hormones, and arteriovenous differences in postprandial glucose levels in type 2 diabetic rats

Some people take it to improve muscle pain and muscle damage (myopathy) due to statins

Homecare/Direct-to-Patient: The homecare segment is expected to grow rapidly, driven by the increasing demand for home healthcare services and advancements in telemedicine

In research settings, Ipamorelin is often linked with faster recovery from physical stress, including workouts and injuries

Safety Considerations and Who Should Proceed Cautiously Patients with active IBS-C, history of severe constipation, or bowel obstruction should approach GLP-1 therapy with particular caution

Cannabis may counteract Ozempic's appetite-suppressing effects and cause unpredictable fluctuations in blood glucose levels